SOURCE: Horizon Pharma

Horizon Pharma

February 04, 2014 07:30 ET

Horizon Pharma to Present at the 16th Annual BIO CEO and Investor Conference

DEERFIELD, IL--(Marketwired - Feb 4, 2014) -  Horizon Pharma, Inc. (NASDAQ: HZNP) today announced Timothy P. Walbert, chairman, president and chief executive officer, is scheduled to present at the 16th Annual BIO CEO and Investor Conference on Tuesday, February 11, 2014 at 2:00pm Eastern Time in New York, NY. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at A replay of the webcast will be available for 10 business days.

About Horizon Pharma
Horizon Pharma, Inc. is a commercial stage, specialty pharmaceutical company that markets DUEXIS®, RAYOS®/LODOTRA® and VIMOVO®, which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The Company's strategy is to develop, acquire or in-license additional innovative medicines or companies where it can execute a targeted commercial approach among specific target physicians such as primary care physicians, orthopedic surgeons and rheumatologists, while taking advantage of its commercial strengths and the infrastructure the Company has put in place. For more information, please visit

Contact Information

  • Contacts
    Robert J. De Vaere
    Executive Vice President and Chief Financial Officer
    Email Contact